BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 33969463)

  • 1. Minimally Invasive Versus Open Pancreatectomy for Right-Sided and Left-Sided G1/G2 Nonfunctioning Pancreatic Neuroendocrine Tumors: A Multicenter Matched Analysis with an Inverse Probability of Treatment-Weighting Method.
    Hwang HK; Song KB; Park M; Kwon W; Jang JY; Heo JS; Choi DW; Kang CM; Park JS; Hong TH; Cho CK; Ahn KS; Lee H; Lee SE; Jeong CY; Roh YH; Kim HJ; Hwang DW; Kim SC; Han HS; Yoon YS;
    Ann Surg Oncol; 2021 Nov; 28(12):7742-7758. PubMed ID: 33969463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Minimally Invasive vs Open Pancreatectomy for Pancreatic Neuroendocrine Tumors: Multi-Institutional 10-Year Experience of 1,023 Patients.
    Zheng J; Pulvirenti A; Javed AA; Michelakos T; Paniccia A; Lee KK; Ferrone CR; Wei AC; He J; Zureikat AH;
    J Am Coll Surg; 2022 Aug; 235(2):315-330. PubMed ID: 35839409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Minimally invasive
    Kim J; Hwang HK; Lee WJ; Kang CM
    World J Gastrointest Oncol; 2020 Oct; 12(10):1133-1145. PubMed ID: 33133382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The clinicopathologic and operative characteristics of patients with small nonfunctioning pancreatic neuroendocrine tumors.
    Ha S; Song KB; Hong S; Shin D; Park Y; Kwon J; Lee W; Jun E; Lee JH; Hwang DW; Kim SC
    ANZ J Surg; 2021 Jul; 91(7-8):E484-E492. PubMed ID: 34291544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of clinical outcomes between enucleation and regular pancreatectomy in patients with non-functional pancreatic neuroendocrine tumors: a retrospective multicenter and propensity score-matched study.
    Yang Z; Gao H; Lu J; Niu Z; Zhu H; Zong Y; Song X; Yang F; Zhou X
    Jpn J Clin Oncol; 2021 Apr; 51(4):595-603. PubMed ID: 33395471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Minimally invasive RAMPS in well-selected left-sided pancreatic cancer within Yonsei criteria: long-term (>median 3 years) oncologic outcomes.
    Lee SH; Kang CM; Hwang HK; Choi SH; Lee WJ; Chi HS
    Surg Endosc; 2014 Oct; 28(10):2848-55. PubMed ID: 24853839
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcomes after distal pancreatectomy for neuroendocrine neoplasms: a retrospective comparison between minimally invasive and open approach using propensity score weighting.
    Partelli S; Andreasi V; Rancoita PMV; Perez-Sanchez E; Muffatti F; Balzano G; Crippa S; Di Serio C; Falconi M
    Surg Endosc; 2021 Jan; 35(1):165-173. PubMed ID: 31953734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Laparoscopic versus open distal pancreatectomy for nonfunctioning pancreatic neuroendocrine tumors: a large single-center study.
    Han SH; Han IW; Heo JS; Choi SH; Choi DW; Han S; You YH
    Surg Endosc; 2018 Jan; 32(1):443-449. PubMed ID: 28664429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Minimally invasive versus open distal pancreatectomy for pancreatic neuroendocrine tumors: An analysis from the U.S. neuroendocrine tumor study group.
    Zhang XF; Lopez-Aguiar AG; Poultsides G; Makris E; Rocha F; Kanji Z; Weber S; Fields R; Krasnick BA; Idrees K; Smith PM; Cho C; Schmidt CR; Maithel SK; Pawlik TM;
    J Surg Oncol; 2019 Aug; 120(2):231-240. PubMed ID: 31001868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pancreatic neuroendocrine tumors: Surgical outcomes and survival analysis.
    Fahmy JN; Varsanik MA; Hubbs D; Eguia E; Abood G; Knab LM
    Am J Surg; 2021 Mar; 221(3):529-533. PubMed ID: 33375953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is laparoscopic resection adequate in patients with neuroendocrine pancreatic tumors?
    Fernández-Cruz L; Blanco L; Cosa R; Rendón H
    World J Surg; 2008 May; 32(5):904-17. PubMed ID: 18264824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Propensity score-matched analysis of clinical outcome after enucleation versus regular pancreatectomy in patients with small non-functional pancreatic neuroendocrine tumors.
    Weilin M; Xu H; Yang L; Wenqi C; Huanyu W; Wentao Z; Dayong J; Wenchuan W; Dansong W; Tiantao K; Lei Z; Wenhui L; Xuefeng X
    Pancreatology; 2020 Mar; 20(2):169-176. PubMed ID: 31941586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-Term Outcomes after Spleen-Preserving Distal Pancreatectomy for Pancreatic Neuroendocrine Tumors: Results from the US Neuroendocrine Study Group.
    Sahara K; Tsilimigras DI; Moro A; Mehta R; Dillhoff M; Heidsma CM; Lopez-Aguiar AG; Maithel SK; Rocha FG; Kanji Z; Abbott DE; Fisher A; Fields RC; Krasnick BA; Idrees K; Smith PM; Poultsides GA; Makris E; Cho CS; Beems M; Endo I; Pawlik TM
    Neuroendocrinology; 2021; 111(1-2):129-138. PubMed ID: 32040951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimal surgical management of unifocal vs. multifocal NF-PNETs: a respective cohort study.
    Kim J; Hong SS; Kim SH; Hwang HK; Kang CM
    World J Surg Oncol; 2024 Apr; 22(1):115. PubMed ID: 38671431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Short-term and long-term outcomes after robot-assisted versus laparoscopic distal pancreatectomy for pancreatic neuroendocrine tumors (pNETs): a multicenter comparative study.
    Alfieri S; Butturini G; Boggi U; Pietrabissa A; Morelli L; Vistoli F; Damoli I; Peri A; Fiorillo C; Pugliese L; Ramera M; De Lio N; Di Franco G; Esposito A; Landoni L; Rosa F; Menghi R; Doglietto GB; Quero G;
    Langenbecks Arch Surg; 2019 Jun; 404(4):459-468. PubMed ID: 31055639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved oncologic outcomes for minimally invasive left pancreatectomy: Propensity-score matched analysis of the National Cancer Database.
    Watson MD; Baimas-George MR; Thompson KJ; Iannitti DA; Ocuin LM; Baker EH; Martinie JB; Vrochides D
    J Surg Oncol; 2020 Dec; 122(7):1383-1392. PubMed ID: 32772366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overestimated Oncologic Significance of Lymph Node Metastasis in G1 Nonfunctioning Neuroendocrine Tumor in the Left Side of the Pancreas.
    Yoo YJ; Yang SJ; Hwang HK; Kang CM; Kim H; Lee WJ
    Medicine (Baltimore); 2015 Sep; 94(36):e1404. PubMed ID: 26356692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determinants of surgical resection for pancreatic neuroendocrine tumors.
    Doi R
    J Hepatobiliary Pancreat Sci; 2015 Aug; 22(8):610-7. PubMed ID: 25773163
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognosis analysis of patients with pancreatic neuroendocrine tumors after surgical resection and the application of enucleation.
    Chen J; Yang Y; Liu Y; Kan H
    World J Surg Oncol; 2021 Jan; 19(1):11. PubMed ID: 33436017
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Short- and long-term outcomes of laparoscopic organ-sparing resection in pancreatic neuroendocrine tumors: a single-center experience.
    Cienfuegos JA; Salguero J; Núñez-Córdoba JM; Ruiz-Canela M; Benito A; Ocaña S; Zozaya G; Martí-Cruchaga P; Pardo F; Hernández-Lizoáin JL; Rotellar F
    Surg Endosc; 2017 Oct; 31(10):3847-3857. PubMed ID: 28127714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.